Suppression of lymphocyte spontaneous proliferative response by proteolipid protein peptide in patients with HAM/TSP.
To understand the immune mechanism suggested in HTLV-I-associated myelopathy (HAM/TSP), we investigated T cell response to proteolipid protein (PLP). Because of high autologous proliferative response (APR) of peripheral blood mononuclear cells (PBMC) in culture, the lymphocyte proliferation assay was not useful in this disease. Unexpectedly, however, APR was profoundly (70-98%) suppressed in 6 of 9 cases when PLP peptide 105-124 was added in the culture. PLP peptide 85-104 or 145-159 also suppressed APR in a few cases. Time course study showed that the peptide-mediated suppression became apparent after day 4 in culture. The results can be interpreted as that suppressor cells recognizing the PLP peptides were present in the PBMC of HAM/TSP patients and suppressed the APR as the consequence of antigen specific response. This may indicate that a T cell response to certain PLP determinants is involved in the pathomechanism of HAM/TSP at least in part. Molecular mimicry between PLP and HTLV-I may account for the T cell sensitization to PLP in HAM/TSP.
Tabira
T
T
Department of Demyelinating Disease and Aging, National Institute of Neuroscience, NCNP, Tokyo, Japan.
Inobe
J
J
Nakahara
K
K
Osame
M
M
Yamamura
T
T
D000328:Adult; D000368:Aged; D000595:Amino Acid Sequence; D002455:Cell Division / Q000187:drug effects; D003864:Depression, Chemical; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009185:Myelin Proteins / Q000494:pharmacology*; D018991:Myelin Proteolipid Protein; D015493:Paraparesis, Tropical Spastic / Q000473:pathology*; D010446:Peptide Fragments / Q000494:pharmacology*; D017386:Sequence Homology, Amino Acid; D013601:T-Lymphocytes / Q000166:cytology / Q000187:drug effects*
D009185:Myelin Proteins; D018991:Myelin Proteolipid Protein; D010446:Peptide Fragments